# Bacteriology and Inflammation in Bronchiectasis

> **NCT01761214** · NA · UNKNOWN · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 80 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Fluroquinolones
- **DRUG:** Beta-lactamase inhibitor

## Key facts

- **NCT ID:** NCT01761214
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761214, "Bacteriology and Inflammation in Bronchiectasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01761214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*